Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis

Archives of Dermatology

Volumn 133, Issue 7, 1997, Pages 867-871

  Paul, Carle ^a   Le Tourneau, Agnés ^b   Cayuela, Jean Michel ^a   Devidas, Alain ^c   Robert, Caroline ^a   Molinié, Vincent ^b   Dubertret, Louis ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c CENTRE HOSPITALIER SUD FRANCILIEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETRETINATE; FOLINATE CALCIUM; METHOTREXATE; PREDNISONE; PSORALEN; VINCRISTINE SULFATE;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MALE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; ULTRAVIOLET A RADIATION;

EID: 0030740890     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.7.867     Document Type: Article

References (34)

1. Weinblatt ME. Methotrexate for chronic diseases in adults. N Engl J Med. 1995; 332:333-334.
2. Zieglschmid-Adams ME, Pandya AG, Cohen SB, Sontheimer RD. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol. 1995;32:754-757.
3. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155:846-851.
4. Mitchell MS, Wade ME, DeConti RC. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med. 1969;70:735.
5. Stenger AAME, Houtman PM, Bruyn GAW, Eggin KHF, Pasma HR. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand J Rheumatol. 1994;23:51-53.
6. Antonelli MAS, Moreland LW, Brick JE. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med. 1991;90:295-298.
7. Kamel OW, Van De Rijn M, Weiss LM, et al. Reversible lymphomas associated with Epstein-Barr virus during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317-1321.
8. Ellman MH, Hurwitz H, Chinnama T, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741-1743.
9. Santana V, Rose NR. Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunopathol. 1992;63:205-213.
10. Marlier S, Chagnon A, Brocq O, et al. Lymphome sous methotrexate à faible dose au cours d'une polyarthrite rhumatoide avec lymphopénie extrême. Ann Med Int. 1995;146:206-208.
11. Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwell DS. Association of methotrexate, rheumatoid arthritis and lymphoma: report of two cases and literature review. J Rheumatol. 1992;19:1462-1465.
12. Liote F, Pertuiset E, Cochand-Priollet B, et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection. J Rheumatol. 1995;22:1174-1178.
13. Viraben R, Brousse P, Lamant L. Reversible cutaneous lymphoma occurring during methotrexate therapy. Br J Dermatol. 1996;135:116-118.
14. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum. 1996;39:325-329.
15. Van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamef OW. Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:638-642.
16. Thomason RW, Craig FE, Banks PM, Sears DL, Myerson GE, Gulley ML. Epstein-Barr virus and lymphoproliferation in methotrexate treated rheumatoid arthritis. Mod Pathol. 1996;9:261-266.
17. Park CK, Ko YH. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin: an in situ hybridization study. Br J Dermatol. 1996;134:488-493.
18. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
19. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986;47:883-889.
20. Deane M, Norton J. Immunoglobin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukaemias. Leukemia. 1990;5:832-838.
21. Bachelez H, Bioul L, Flageul B, et al. Detection of clonal T-cell receptor g gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome. Arch Dermatol. 1995;131: 1027-1031.
22. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85:307-311.
23. Moder KG, Tefferi A, Cohen MD, et al. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med. 1995;99: 276-281.
24. Bailin PL, Tindall JP, Roenigk HH Jr. Is methotrexate therapy for psoriasis carcinogenic? a modified retrospective-prospective analysis. JAMA. 1975;232:359-362.
25. Nyfors A, Jensen H. Frequency of malignant neoplasms in 248 long-term methotrexate treated psoriatics. Dermatologica. 1983;167:260-261.
26. Stern RS, Zierler S, Parrish JA. Methotrexate used for psoriasis and the risk of noncutaneous and cutaneous malignancy. Cancer. 1982;50:869-872.
27. Schröter R, Kelleter R, Kuhn D. Reticulosis as a long term side-effect of methotrexate therapy in a patient with generalized psoriasis and psoriatic arthritis. Dermatologica. 1971;143:131-136.
28. Morison VA, Dunn DL, Manivel JC, Gajt-Peczalska KJ, Peterson BA. Clinical characteristics of post transplant lymphoproliferative disorders. Am J Med. 1994; 97:14-24.
29. Lidskov R, Wuff HC, Wantzin GL, Niebuhr E. Sister chromatid exchange in patients treated with methotrexate for psoriasis. J Invest Dermatol. 1984;82:458-459.
30. Murray RJ, Kurilla MG, Brooks JM, et al. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus: implications for the immune control of EBV-positive malignancies. J Exp Med. 1992;176:157-168.
31. Zijlmans JMJM, Van Rijthoven AWAM, Kluin PM, et al. Epstein-Barr virus associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine. N Engl J Med. 1992;326:1363.
32. Larvol L, Soule J-C, Le Tourneau A. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. N Engl J Med. 1994;331:883-884.
33. Kamel OW, Van de Rijn M, Hanasono MM, Warnke RA. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leuk Lymphoma. 1995;16:363-368.
34. Ferraccioli GF, Casatta L, Bartoli E, et al. Epstein-Barr virus associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum. 1995;38:867-868.